CYP2D6 gene variants in urban/admixed and Amerindian populations of Venezuela: Pharmacogenetics and anthropological implications

References

• Agúndez JA, Ramirez R, Hernandez M, Llerena A, Benítez J. 1997. Molecular heterogeneity at the CYP2D gene locus in Nicaraguans: impact of gene-flow from Europe. Pharmacogenetics. 7:337–740.
   PubMedGoogle Scholar
• Bailliet G, Santos MR, Alfaro EL, Dipierri JE, Demarchi DA, Carnese FR, Bianchi NO. 2007. Allele and genotype frequencies of metabolic genes in Native Americans from Argentina and Paraguay. Mutat Res. 627:171–177.
   PubMed Web of Science ®Google Scholar
• Bortolini MC, Salzano FM, Bau CH, Layrisse Z, Petzl-Erler ML, Tsuneto LT, Hill K, Hurtado AM, Castro-De-Guerra D, Bedoya G, Ruiz-Linares A. 2002. Y-chromosome biallelic polymorphisms and Native American population structure. Ann Hum Genet. 66:255–259.
   PubMedGoogle Scholar
• Bortolini MC, Salzano FM, Thomas MG, Stuart S, Nasanen SP, Bau CH, Hutz MH, Layrisse Z, Petzl-Erler ML, Tsuneto LT, Hill K, Hurtado AM, Castro-de-Guerra D, Torres MM, Groot H, Michalski R, Nymadawa P, Bedoya G, Bradman N, Labuda D, Ruiz-Linares A. 2003. Y-chromosome evidence for differing ancient demographic histories in the Americas. Am J Hum Genet. 73:524–539.
   PubMedGoogle Scholar
• Bradford LD. 2002. CYP2D6 allele frequency in European Caucasians, Asians, Africans and their descendants. Pharmacogenomics. 3:229–243.
   PubMed Web of Science ®Google Scholar
• Brito F. 1966. Historia Economica y Social de Venezuela, una Estructura para su Estudio. Caracas, Venezuela: Direccion de Cultura, Universidad Central de Venezuela.
   Google Scholar
• Crescenti A, Mas S, Gassó P, Baiget M, Bernardo M, Lafuente A. 2007. Simultaneous genotyping of CYP2D6*3, *4, *5 and *6 polymorphisms in a Spanish population through multiplex long polymerase chain reaction and minisequencing multiplex single base extension analysis. Clin Exp Pharmacol Physiol. 34:992–997.
   PubMed Web of Science ®Google Scholar
• Evans WE, Relling MV. 2004. Moving towards individualized medicine with pharmacogenomics. Nature. 429:464–468.
   PubMed Web of Science ®Google Scholar
• Fuselli S, de Filippo C, Mona S, Sistonen J, Fariselli P, Destro-Bisol G, Barbujani G, Bertorelle G, Sajantila A. 2010. Evolution of detoxifying systems: the role of environment and population history in shaping genetic diversity at human CYP2D6 locus. Pharmacogenet Genomics. 20:485–499.
   PubMed Web of Science ®Google Scholar
• Gaedigk A, Bradford LD, Marcucci KA, Leeder JS. 2002. Unique CYP2D6 activity distribution and genotype-phenotype discordance in black Americans. Clin Pharmacol Ther. 72:76–89.
   PubMed Web of Science ®Google Scholar
• Gendzekhadze K, Herrera F, Montagnani S, Balbas O, Witter K, Albert E, Layrisse Z. 2004. HLA-DP polymorphism in Venezuelan Amerindians. Hum Immunol. 65:1483–1488.
   PubMedGoogle Scholar
• Guerra DC, Pérez CF, Izaguirre MH, Barahona EA, Larralde AR, Lugo MV. 2011. Gender differences in ancestral contribution and admixture in Venezuelan populations. Hum Biol. 83:345–361.
   PubMedGoogle Scholar
• Hersberger M, Marti-Jaun J, Rentsch K, Hänseler E. 2000. Rapid detection of the CYP2D6*3, CYP2d6*4, and CYP2D6*6 alleles by tetraprimer PCR and of the CYP2D6*5 allele by multiplex long PCR. Clin Chem. 46:1072–1077.
   PubMed Web of Science ®Google Scholar
• Human Cytochrome P450 (CYP) Allele Nomenclature Committee. Available online at www.cypalleles.ki.se/cyp2d6.htm, accessed 5 July 2011..
   Google Scholar
• Ingelman-Sundberg M. 2005. Genetic polymorphisms of cytochrome P450 2D6 (CYP2D6): clinical consequences, evolutionary aspects and functional diversity. Pharmacogenomics J. 5:6–13.
   PubMed Web of Science ®Google Scholar
• Ingelman-Sundberg M, Sim SC, Gomez A, Rodriguez-Antona C. 2007. Influence of cytochrome P450 polymorphisms on drug therapies: pharmacogenetic, pharmacoepigenetics and clinical aspects. Pharmacol Ther. 116:496–526.
   PubMed Web of Science ®Google Scholar
• Isaza CA, Henao J, López AM, Cacabelos R. 2000. Isolation, sequence and genotyping of the drug metabolizer CYP2D6 gene in the Colombian population. Methods Find Exp Clin Pharmacol. 22:695–705.
   PubMed Web of Science ®Google Scholar
• Jaja C, Burke W, Thummel K, Edwards K, Veenstra DL. 2008. Cytochrome p450 enzyme polymorphism frequency in indigenous and Native American populations: a systematic review. Community Genet. 11:141–149.
   PubMedGoogle Scholar
• Ji L, Pan S, Marti-Jaun J, Hänseler E, Rentsch K, Hersberger M. Single step assay to analyze CYP2D6 gene polymorphism in Asian: allele frequency and a novel *14b allele in Mainland Chinese. Clin Chem. 2002a; 48:938–988.
   Google Scholar
• Ji L, Pan S, Wu J, Marti-Jaun J, Hersberger M. Genetic polymorphisms of CYP2D6 in Chinese mainland. Chin Med J. 2002b; 115:1780–1784.
   PubMedGoogle Scholar
• Jorge LF, Eichelbaum M, Griese EU, Inaba T, Arias TD. 1999. Comparative evolutionary pharmacogenetics of CYP2D6 in Ngawbe and Embera Amerindians of Panama and Colombia: role of selection versus drift in world populations. Pharmacogenetics. 9:217–228.
   PubMedGoogle Scholar
• Jurima-Romet M, Foster BC, Casley WL, Rode A, Vloshinsky P, Huang HS, Geertsen S. 1997. CYP2D6-related oxidation polymorphism in a Canadian Inuit population. Can J Physiol Pharmacol. 75:165–172.
   PubMed Web of Science ®Google Scholar
• Lewis MP (editor). 2009. Ethnologue: Languages of the World, 16th ed., Dallas, Texas: SIL international.
   Google Scholar
• Lizarralde R, Beckerman S. 1982. Historia contemporánea de los bari. Antropológica. 58:3–52.
   Google Scholar
• Lopez M, Guerrero J, Jung-Cook H, Alonso ME. 2005. CYP2D6 genotype and phenotype determination in a Mexican Mestizo population. Eur J Clin Pharmacol. 61:749–754.
   PubMed Web of Science ®Google Scholar
• Man M, Farmen M, Dumaual C, Teng CH, Moser B, Irie S, Noh GJ, Njau R, Close S, Wise S, Hockett R. 2010. Genetic variation in metabolizing enzyme and transporter genes: comprehensive assessment in 3 major East Asian subpopulations with comparison to Caucasians and Africans. J Clin Pharmacol. 50:929–940.
   PubMed Web of Science ®Google Scholar
• Menoyo A, del Rio E, Baiget M. 2006. Characterization of variant alleles of cytochrome CYP2D6 in a Spanish population. Cell Biochem Funct. 24:381–385.
   PubMed Web of Science ®Google Scholar
• Muñoz S, Vollrath V, Vallejos MP, Miquel JF, Covarrubias C, Raddatz A, Chianale J. 1998. Genetic polymorphisms of CYP2D6, CYP1A1 and CYP2E1 in the South-Amerindian population of Chile. Pharmacogenetics. 8:343–351.
   PubMedGoogle Scholar
• Neafsey P, Ginsberg G, Hattis D, Sonawane B. 2009. Genetic polymorphism in cytochrome P450 2D6 (CYP2D6): population distribution of CYP2D6 activity. J Toxicol Environ Health B Crit Rev. 12:334–361.
   PubMed Web of Science ®Google Scholar
• Pardo-Govea T, Borjas L, Zabala W, Sánchez M, Portillo M, Aranguren A. 2007. Marcadores polimorficos del cromosoma-Y en grupos indígenas del estado Zulia. Venezuela. Ciencia. 15:341–348.
   Google Scholar
• Rodríguez-Larralde A, Castro de Guerra D, Gonzalez M, Morales J. 2001. Frecuencia génica y porcentaje de mezcla en diferentes áreas geográficas de Venezuela, de acuerdo a los grupos Rh y ABO. Interciencia. 26:8–12.
   Google Scholar
• Shimizu T, Ochiai H, Asell F, Yokono Y, Kikuchi Y, Nitta M, Hama Y, Yamaguchi S, Hashimoto M, Taki K, Nakata K, Aida Y, Ohashi A, Ozawa N. 2003. Bioinformatics research on inter-racial difference in drug metabolism II. Analysis on relationship between enzyme activities of CYP2D6 and CYP2C19 and their relevant genotypes. Drug Metab Pharmacokinet. 18:71–78.
   PubMedGoogle Scholar
• Sistonen J, Fuselli S, Palo JU, Chauhan N, Padh H, Sajantila A. 2009. Pharmacogenetic variation at CYP2C9, CYP2C19, and CYP2D6 at global and microgeographic scales. Pharmacogenet Genomics. 19:170–179.
   PubMed Web of Science ®Google Scholar
• Sistonen J, Sajantila A, Lao O, Corander J, Barbujani G, Fuselli S. 2007. CYP2D6 worldwide genetic variation shows high frequency of altered activity variants and no continental structure. Pharmacogenet Genomics. 17:93–101.
   PubMed Web of Science ®Google Scholar
• Sosa-Macías M, Elizondo G, Flores-Pérez C, Flores-Pérez J, Bradley-Alvarez F, Alanis-Bañuelos RE, Lares-Asseff I. 2006. CYP2D6 genotype and phenotype in Amerindians of Tepehuano origin and Mestizos of Durango. Mexico. J Clin Pharmacol. 46:527–536.
   PubMed Web of Science ®Google Scholar
• Suarez-Kurtz G, Pena SD. 2006. Pharmacogenomics in the Americas: the impact of genetic admixture. Curr Drug Targets. 7:1649–1658.
   PubMed Web of Science ®Google Scholar
• Zhou SF. 2009. Polymorphism of human cytochrome P450 2D6 and its clinical significance: part I. Clin Pharmacokinet. 48:689–723.
   PubMed Web of Science ®Google Scholar